Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!
BTG Plc |
Publisher Contact: Press Office - BTGplc.com
+44(0)20 7575 1513 media[.]btgplc.com
|Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Biocompatibles UK Ltd / BTG Plc securities in any jurisdiction including any other companies listed or named in this release.
|Pharma / BioTech / Nutrition via RSS
Find who RetweetFollow @NewswireTODAY
|Read Latest Articles From Biocompatibles UK Ltd / BTG Plc / Company Profile|
|Huami Corp and Royal DSM Announce Collaboration on Wearable Technologies and Health Tracking for Personalized Nutrition|
|DSM Expands Animal Nutrition & Health Operations in China with Opening of Seventh Premix Plant|
|Biosurfactants and Natural Preservatives Drive Innovation for Functional Ingredients in Personal Care Market Finds Frost & Sullivan|
|Ypsomed Collaborates with SCHOTT and Lonza to Develop A Comprehensive Solution for Combination Products Based on Patch Injectors|
|DSM Unveils Purpose-led Brand Strategy Marking Transition to End-to-end Partner in Nutrition and Health|
|Ipsen to Present 12 Abstracts At the 11th World Congress for Neurorehabilitation (WCNR) Virtual Congress|
|Imec Announces elPrep5 - the Newest Version of its Software Platform for DNA Analysis|
|Ipsen Showcases Commitment to Patient-centric Advances in Oncology with Record Number of Abstracts to be Presented At ESMO 2020 Virtual Congress|
|Global Phase 3 Clinical Study of Pridopidine in Huntington’s Disease Announced|
|Ipsen to Present New Insights At ASBMR for Potential Treatment of Ultra-rare Disease Fibrodysplasia Ossificans Progressiva (FOP)|
|Ipsen to Present Results from MOVE, the First Global Phase III Trial in Fibrodysplasia Ossificans Progressiva (FOP) At ASBMR 2020 Annual Meeting|
|DSM Ignites New Strategic Initiative to Transform Global Animal Nutrition and Health|
|Jamjoom Pharmaceuticals Earns Acclaim from Frost & Sullivan for its Dominance in the KSA Pharma Market|
|DSM and Avril Complete Creation of Joint Venture to Develop Plant-based Protein|
|Ipsen Joins Clinical Collaboration to Evaluate Cabozantinib (CABOMETYX®) Plus Atezolizumab in Metastatic Non-small Cell Lung Cancer|
|Boost Your Social Network|
& Crowdfunding Campaigns